Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02739581

Efficacy and Safety of Endoscopic Variceal Ligation (EVL) Versus EVL Plus Non-selective B-blockers (NSBB) For Prevention of Variceal Rebleed and Non-bleed Related Complications in Patients With Advanced Cirrhosis

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Institute of Liver and Biliary Sciences, India · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The patients will be randomized into two groups 1. Endoscopic Variceal Ligation with Non Selective Beta Blocker 2. Placebo with Endoscopic Variceal Ligation

Conditions

Interventions

TypeNameDescription
PROCEDUREEndoscopic Variceal Ligation
DRUGNon selective beta blocker
OTHERPlacebo

Timeline

Primary completion
2019-04-01
Completion
2019-04-01
First posted
2016-04-15
Last updated
2019-10-10

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT02739581. Inclusion in this directory is not an endorsement.